A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
National Institutes of Health Clinical Center (CC)
NGM Biopharmaceuticals, Inc
Elevation Oncology
Stanford University
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
pharmaand GmbH
Genmab
Ludwig Institute for Cancer Research
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Seagen Inc.
Gilead Sciences
Incyte Corporation
Seagen Inc.
Eli Lilly and Company
University of Kansas Medical Center
Roswell Park Cancer Institute
Amgen
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
INSYS Therapeutics Inc
Altor BioScience
GlaxoSmithKline